// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

N. Suresh - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

R. Ibrahim - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

N. Manu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Klatskin tumors

N/A

A. Hann - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Thrombocytopenia

N/A

K. Ammar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreatitis

N/A

E. Jerome - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

J. Sijberden - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

E. Jerome - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Secondary liver cancer

Oxaliplatin, 5-fluorouracil and folic acid

E. Jerome - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

S. Aroori - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

S. Biggs - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

T.B. Russell - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

P. Estridge - International Hepato-Pancreato-Biliary Association (IHPBA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Constantin-Cristian Topriceanu - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Anenta Ramakrishnan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular hypertrophy

N/A

Joyee Basu - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Harish Sharma - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral valve regurgitation

N/A

Zaid Iskandar - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Marfan syndrome

N/A

Thomas Rance - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Laxmi Kaliyappan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A